Know Cancer

or
forgot password

Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk


N/A
18 Years
35 Years
Not Enrolling
Male
Testicular Cancer

Thank you

Trial Information

Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk


Inclusion Criteria:



- Patients with infertility azoospermia

- Age 18 to 35 years

- Definition of clinical and biological character of azoospermia: testicular volume
less than 10 ml and FSH more than 10 IU / l

- Normal karyotype

- Surgical exploration included in a standardized medical aid to procreation

- Testicular biopsy performed by traditional surgery

- Patient informed about the research protocol and having signed consent to conduct a
further testicular biopsy included in this study.

Exclusion Criteria:

- adults protected by law, minors

- Individuals who are not affiliated to a social security

- Subjects hospitalized for any reason other than research.

- Patients will be used to support reproductive techniques:

- Positive serology (HIV, hepatitis ...).

- Patients with karyotype anomalies and unfavourable genetic counselling

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Analysis of 4 recognized tumorogenesis biomarkers in testicular biopsies of a population of hypofertiles men in theory supposed to present an increased incidence of testicular cancer development

Outcome Time Frame:

4 years

Safety Issue:

No

Authority:

France: Direction Générale de la Santé

Study ID:

APN 2004

NCT ID:

NCT00820287

Start Date:

September 2005

Completion Date:

June 2011

Related Keywords:

  • Testicular Cancer
  • Testicular cancer
  • incidence
  • young men
  • Testicular Neoplasms

Name

Location